BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

842 related articles for article (PubMed ID: 31971931)

  • 21. Update: Demographic, Product, and Substance-Use Characteristics of Hospitalized Patients in a Nationwide Outbreak of E-cigarette, or Vaping, Product Use-Associated Lung Injuries - United States, December 2019.
    Lozier MJ; Wallace B; Anderson K; Ellington S; Jones CM; Rose D; Baldwin G; King BA; Briss P; Mikosz CA;
    MMWR Morb Mortal Wkly Rep; 2019 Dec; 68(49):1142-1148. PubMed ID: 31830008
    [No Abstract]   [Full Text] [Related]  

  • 22. Patient Characteristics and Product Use Behaviors Among Persons with E-cigarette, or Vaping, Product Use-Associated Lung Injury - Indiana, June ̶ October 2019.
    Gaub KL; Hallyburton S; Samanic C; Paddack D; Clark CR; Pence S; Brown JA; Hawkins E
    MMWR Morb Mortal Wkly Rep; 2019 Dec; 68(49):1139-1141. PubMed ID: 31830007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The E-cigarette or Vaping Product Use-Associated Lung Injury Epidemic: Pathogenesis, Management, and Future Directions: An Official American Thoracic Society Workshop Report.
    Rebuli ME; Rose JJ; Noël A; Croft DP; Benowitz NL; Cohen AH; Goniewicz ML; Larsen BT; Leigh N; McGraw MD; Melzer AC; Penn AL; Rahman I; Upson D; Crotty Alexander LE; Ewart G; Jaspers I; Jordt SE; Kligerman S; Loughlin CE; McConnell R; Neptune ER; Nguyen TB; Pinkerton KE; Witek TJ
    Ann Am Thorac Soc; 2023 Jan; 20(1):1-17. PubMed ID: 36584985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Review of Health Consequences of Electronic Cigarettes and the Outbreak of Electronic Cigarette, or Vaping, Product Use-Associated Lung Injury.
    Cao DJ; Aldy K; Hsu S; McGetrick M; Verbeck G; De Silva I; Feng SY
    J Med Toxicol; 2020 Jul; 16(3):295-310. PubMed ID: 32301069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. E-cigarette, or vaping, product use associated lung injury (EVALI): case series and diagnostic approach.
    Kalininskiy A; Bach CT; Nacca NE; Ginsberg G; Marraffa J; Navarette KA; McGraw MD; Croft DP
    Lancet Respir Med; 2019 Dec; 7(12):1017-1026. PubMed ID: 31711871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Evolution of a Pediatric Public Health Crisis: E-cigarette or Vaping-Associated Lung Injury.
    Barker CK; Ghera P; Hsu B
    Pediatrics; 2024 May; 153(5):. PubMed ID: 38629169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of vaping-related lung injuries with rates of e-cigarette and cannabis use across US states.
    Friedman AS
    Addiction; 2021 Mar; 116(3):651-657. PubMed ID: 32840932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vitamin E Acetate in Bronchoalveolar-Lavage Fluid Associated with EVALI.
    Blount BC; Karwowski MP; Shields PG; Morel-Espinosa M; Valentin-Blasini L; Gardner M; Braselton M; Brosius CR; Caron KT; Chambers D; Corstvet J; Cowan E; De Jesús VR; Espinosa P; Fernandez C; Holder C; Kuklenyik Z; Kusovschi JD; Newman C; Reis GB; Rees J; Reese C; Silva L; Seyler T; Song MA; Sosnoff C; Spitzer CR; Tevis D; Wang L; Watson C; Wewers MD; Xia B; Heitkemper DT; Ghinai I; Layden J; Briss P; King BA; Delaney LJ; Jones CM; Baldwin GT; Patel A; Meaney-Delman D; Rose D; Krishnasamy V; Barr JR; Thomas J; Pirkle JL;
    N Engl J Med; 2020 Feb; 382(8):697-705. PubMed ID: 31860793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Examining the temporality of vitamin E acetate in illicit THC-containing e-cigarette, or vaping, products from a public health and law enforcement response to EVALI - Utah, 2018-2020.
    Arons MM; Barnes SR; Cheng R; Whittle K; Elsholz C; Bui D; Gilley S; Maldonado A; LaCross N; Sage K; Lewis N; McCaffrey K; Green J; Duncan J; Dunn AC
    Int J Drug Policy; 2021 Feb; 88():103026. PubMed ID: 33246266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemical Emissions From Heated Vitamin E Acetate-Insights to Respiratory Risks From Electronic Cigarette Liquid Oil Diluents Used in the Aerosolization of Δ
    LeBouf RF; Ranpara A; Ham J; Aldridge M; Fernandez E; Williams K; Burns DA; Stefaniak AB
    Front Public Health; 2021; 9():765168. PubMed ID: 35127617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaping Associated Lung Injury (EVALI): An Explosive United States Epidemic.
    Salzman GA; Alqawasma M; Asad H
    Mo Med; 2019; 116(6):492-496. PubMed ID: 31911735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. E-cigarette or Vaping Product Use-Associated Lung Injury (EVALI) Without Respiratory Symptoms.
    Matta P; Hamati JN; Unno HL; Fox MD
    Pediatrics; 2020 May; 145(5):. PubMed ID: 32317307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. E-cigarette or vaping-associated lung injury (EVALI): a review of international case reports from outside the United States of America.
    Sund LJ; Dargan PI; Archer JRH; Wood DM
    Clin Toxicol (Phila); 2023 Feb; 61(2):91-97. PubMed ID: 36636876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Content Analysis of E-cigarette News Articles Amidst the 2019 Vaping-Associated Lung Injury (EVALI) Outbreak in the United States.
    Jeong M; Singh B; Wackowski OA; Mukherjee R; Steinberg MB; Delnevo CD
    Nicotine Tob Res; 2022 Mar; 24(5):799-803. PubMed ID: 34624099
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipid laden macrophages and electronic cigarettes in healthy adults.
    Shields PG; Song MA; Freudenheim JL; Brasky TM; McElroy JP; Reisinger SA; Weng DY; Ren R; Eissenberg T; Wewers MD; Shilo K
    EBioMedicine; 2020 Oct; 60():102982. PubMed ID: 32919101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hospitalizations and Deaths Associated with EVALI.
    Werner AK; Koumans EH; Chatham-Stephens K; Salvatore PP; Armatas C; Byers P; Clark CR; Ghinai I; Holzbauer SM; Navarette KA; Danielson ML; Ellington S; Moritz ED; Petersen EE; Kiernan EA; Baldwin GT; Briss P; Jones CM; King BA; Krishnasamy V; Rose DA; Reagan-Steiner S;
    N Engl J Med; 2020 Apr; 382(17):1589-1598. PubMed ID: 32320569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Over 1 year later: smokers' EVALI awareness, knowledge and perceived impact on e-cigarette interest.
    Wackowski OA; Gratale SK; Jeong M; Delnevo CD; Steinberg MB; O'Connor RJ
    Tob Control; 2023 Aug; 32(e2):e255-e259. PubMed ID: 35228318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of state portrayals of the risks of e-cigarette use and the cause of the EVALI outbreak.
    Katchmar A; Shafer P; Siegel M
    Harm Reduct J; 2022 Oct; 19(1):112. PubMed ID: 36199112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. E-Cigarette or Vaping Product Use-associated Lung Injury: Developing a Research Agenda. An NIH Workshop Report.
    Crotty Alexander LE; Ware LB; Calfee CS; Callahan SJ; Eissenberg T; Farver C; Goniewicz ML; Jaspers I; Kheradmand F; King TE; Jr ; Meyer NJ; Mikheev VB; Shields PG; Shihadeh A; Strongin R; Tarran R
    Am J Respir Crit Care Med; 2020 Sep; 202(6):795-802. PubMed ID: 32243764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lessons Learned From the E-cigarette, or Vaping, Product Use-Associated Lung Injury (EVALI) Outbreak Response, Minnesota, 2019-2020.
    Wiens T; Taylor J; Cole C; Saravia S; Peterson J; Lunda M; Margetta J; D'Heilly P; Holzbauer S; Lynfield R
    Public Health Rep; 2022; 137(6):1053-1060. PubMed ID: 34694926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.